Footnotes
This manuscript has recently been accepted for publication in the European Respiratory Journal. It is published here in its accepted form prior to copyediting and typesetting by our production team. After these production processes are complete and the authors have approved the resulting proofs, the article will move to the latest issue of the ERJ online. Please open or download the PDF to view this article.
Conflict of interest: Dr Godet reports having received speaker fees, travel support from Pfizer, MSD; fees for board memberships from SOS Oxygène and Pulmatrix; grant support from Ohre Pharma, Pfizer, MSD, SOS Oxygène, ISIS Medical, and AstraZeneca.
Conflict of interest: Dr Cadranel reports having received speaker fees from MSD and Pfizer on pulmonary aspergillosis and for participating on experts grants on cancer drugs. Gants from Pfizer and SOS oxygen for study outside the submitted work.
Conflict of interest: Dr Frat reports having received grants from the French Ministry of Health, outside the submitted work; grants, personal fees and non-financial support from Fisher & Paykel HeathCare, outside the submitted work; personal fees and non-financial support from SOS Oxygène, outside the submitted work.
Conflict of interest: Dr Ragot: no disclosure was reported.
Conflict of interest: Dr Couturaud reports having received research grant support from Bristol-Myers Squibb/Pfizer and fees for board memberships or symposia from Bayer, Bristol-Myers Squibb/Pfizer, Merck Sharp & Dohme and AstraZeneca and having received travel support from Bayer, Bristol-Myers Squibb/Pfizer, Leo Pharma, Merck Sharp & Dohme and Actelion.
This is a PDF-only article. Please click on the PDF link above to read it.
- Received July 2, 2022.
- Accepted September 1, 2022.
- Copyright ©The authors 2022. For reproduction rights and permissions contact permissions{at}ersnet.org